Amundi
RCUS icon

Amundi’s Arcus Biosciences RCUS Stock Holding History

Amundi’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-23,993
Closed -$172K – 2068
2025
Q1 		$172K Sell
23,993
-3,037
-11% -$35.2K ﹤0.01% 1691
2024
Q4 		$403K Buy
27,030
+15,624
+137% +$255K ﹤0.01% 1609
2024
Q3 		$199K Buy
11,406
+1,014
+10% +$16K ﹤0.01% 1659
2024
Q2 		$149K Buy
10,392
+826
+9% +$13.3K ﹤0.01% 1635
2024
Q1 		$142K Buy
9,566
+2,853
+42% +$49.3K ﹤0.01% 1702
2023
Q4 		$125K Hold
6,713
– – ﹤0.01% 1728
2023
Q3 		$108K Hold
6,713
– – ﹤0.01% 1740
2023
Q2 		$137K Buy
+6,713
New +$128K ﹤0.01% 1703

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Amundi's RCUS Position: Q2 2025 in Review

Amundi sold out of Arcus Biosciences (RCUS) in Q2 2025, closing a stake of 23,993 shares — an estimated $172K sold.

Amundi first reported a position in RCUS in Q2 2023 and held it in 8 quarters. The position peaked at $403K in Q4 2024. 185 funds tracked by Wall St. Rank hold RCUS as of Q2 2025.

  • Amundi reported no remaining Arcus Biosciences position as of Q2 2025 after selling out during the quarter.
  • Amundi sold 23,993 Arcus Biosciences shares in Q2 2025, an estimated $172K.
  • Amundi first reported a position in Arcus Biosciences in Q2 2023 and held it in 8 quarters.
  • Amundi's Arcus Biosciences position peaked at $403K in Q4 2024.
  • 185 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2025.

Based on Amundi's 13F filing for Q2 2025, filed 13 Aug 2025.